Status
Global HQ
Lafayette, California
Countries of investment
Investment stages
Industries
About
SynBioBeta is a dynamic network dedicated to fostering connections among individuals who are passionate about biological engineering and sustainability. By bringing together entrepreneurs, investors, and innovators, SynBioBeta facilitates collaborative efforts that drive the responsible advancement of the synthetic biology industry. The organization serves as a pivotal platform for knowledge exchange, networking opportunities, and resource sharing, empowering its members to tackle global challenges through innovative solutions in synthetic biology. As a leader in this transformative field, SynBioBeta is committed to promoting ethical practices and sustainable approaches that benefit both society and the environment.
SynBioBeta is a dynamic network dedicated to fostering connections among individuals who are passionate about biological engineering and sustainability. By bringing together entrepreneurs, investors, and innovators, SynBioBeta facilitates collaborative efforts that drive the responsible advancement of the synthetic biology industry. The organization serves as a pivotal platform for knowledge exchange, networking opportunities, and resource sharing, empowering its members to tackle global challenges through innovative solutions in synthetic biology. As a leader in this transformative field, SynBioBeta is committed to promoting ethical practices and sustainable approaches that benefit both society and the environment.
Investment Thesis
Manager's Experience
With a robust background in biotechnology investing, the fund manager has successfully navigated numerous deals across North America and Europe, totaling over 50 transactions. Their strategic focus leans towards early-stage investments, often emphasizing operator-first approaches to drive innovation. Notable exits include several high-profile IPOs and acquisitions, underscoring their ability to identify and cultivate high-potential companies. The manager’s thematic strategy revolves around cutting-edge sectors such as synthetic biology and personalized medicine, positioning them as a key player in the evolving landscape of life sciences.